Bausch Health Companies Inc. filed a Form 8-K current report on October 28, 2026, announcing results of operations for the quarter ended September 30, 2026, with a press release attached as Exhibit 99.1.

Key Highlights

  • Filing date: October 28, 2026, covering the quarter ended September 30, 2026.
  • Exchange listing: Common Shares (no par value) trade under ticker BHC on both the New York Stock Exchange and the Toronto Stock Exchange, according to the filing.
  • Press release: A press release respecting financial results for the third quarter of 2026, dated October 28, 2026, is incorporated as Exhibit 99.1.
  • Signed by: Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, as Principal Financial Officer.
  • Furnished, not filed: The company disclosed that the information in Item 2.02, including Exhibit 99.1, "is being furnished and shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934."

Bausch Health Reports Third-Quarter 2026 Operating Results via Current Report

Bausch Health Companies Inc. (NYSE:BHC), incorporated in British Columbia, Canada, and headquartered at 2150 St. Elzear Blvd. West, Laval, Quebec, filed an 8-K current report with the U.S. Securities and Exchange Commission on October 28, 2026. The filing was made under Item 2.02, Results of Operations and Financial Condition, and covers the quarter ended September 30, 2026.

According to the filing, the company issued a press release on October 28, 2026, announcing results of operations for the third quarter of 2026 as well as "certain other financial information as of and for the quarter ended September 30, 2026." The actual financial figures are contained in the press release attached as Exhibit 99.1 and are not reproduced in the body of the 8-K itself. The filing also states that the current report and the attached press release "do not constitute an offer to sell or the solicitation of an offer to buy any securities."

The company noted that the information furnished under Item 2.02 and in Exhibit 99.1 "shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended." The report was signed by Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, in his capacity as Principal Financial Officer.

What Was Disclosed

Bausch Health filed an 8-K on October 28, 2026, to announce third-quarter 2026 financial results via an attached press release. The filing identifies Item 2.02 as its basis and designates the disclosure as furnished rather than filed under the Exchange Act.